Evidence map›Paper›PMID 25905470›Full record

ArticlePLoS computational biology2015

Spatial and functional heterogeneities shape collective behavior of tumor-immune networks.

Daniel K Wells, Yishan Chuang, Louis M Knapp, Dirk Brockmann, William L Kath, Joshua N Leonard

Abstract read
In one paragraph

Article in PLoS computational biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Intratumoral Heterogeneity in Ductal Carcinoma In Situ: Chaos and Consequence.Journal of mammary gland biology and neoplasia · 2018
    Review
  18. Article
  19. Review
  20. Biologically Relevant Heterogeneity: Metrics and Practical Insights.SLAS discovery : advancing life sciences R & D · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel K WellsDepartment of Engineering Sciences and Applied Mathematics, Northwestern University, Evanston, Illinois, United States of America; Northwestern University Physical Sciences-Oncology Center, Evanston, Illinois, United States of America.
Yishan ChuangDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, United States of America.
Louis M KnappDepartment of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, United States of America.
Dirk BrockmannDepartment of Engineering Sciences and Applied Mathematics, Northwestern University, Evanston, Illinois, United States of America; Northwestern University Physical Sciences-Oncology Center, Evanston, Illinois, United States of America; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, United States of America; Northwestern Institute on Complex Science, Northwestern University, Evanston, Illinois, United States of America; Institute for Theoretical Biology, Humboldt University Berlin, Berlin, Germany.
William L KathDepartment of Engineering Sciences and Applied Mathematics, Northwestern University, Evanston, Illinois, United States of America; Northwestern University Physical Sciences-Oncology Center, Evanston, Illinois, United States of America; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, United States of America; Northwestern Institute on Complex Science, Northwestern University, Evanston, Illinois, United States of America; Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois, United States of America.
Joshua N LeonardNorthwestern University Physical Sciences-Oncology Center, Evanston, Illinois, United States of America; Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, United States of America; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, Illinois, United States of America; Chemistry of Life Processes Institute, Northwestern University, Evanston, Illinois, United States of America.

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
TRANS-NETWORK PROJECTSU54CA143869 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI KOPP, PETER ANDREAS · 2009 to 2013
$12.8M
NCI NIH HHS U54 CA143869NCI NIH HHS U54 CA143869-05
6 · The paper itself

Abstract

Tumor growth involves a dynamic interplay between cancer cells and host cells, which collectively form a tumor microenvironmental network that either suppresses or promotes tumor growth under different conditions. The transition from tumor suppression to tumor promotion is mediated by a tumor-induced shift in the local immune state, and despite the clinical challenge this shift poses, little is known about how such dysfunctional immune states are initiated. Clinical and experimental observations have indicated that differences in both the composition and spatial distribution of different cell types and/or signaling molecules within the tumor microenvironment can strongly impact tumor pathogenesis and ultimately patient prognosis. How such "functional" and "spatial" heterogeneities confer such effects, however, is not known. To investigate these phenomena at a level currently inaccessible by direct observation, we developed a computational model of a nascent metastatic tumor capturing salient features of known tumor-immune interactions that faithfully recapitulates key features of existing experimental observations. Surprisingly, over a wide range of model formulations, we observed that heterogeneity in both spatial organization and cell phenotype drove the emergence of immunosuppressive network states. We determined that this observation is general and robust to parameter choice by developing a systems-level sensitivity analysis technique, and we extended this analysis to generate other parameter-independent, experimentally testable hypotheses. Lastly, we leveraged this model as an in silico test bed to evaluate potential strategies for engineering cell-based therapies to overcome tumor associated immune dysfunction and thereby identified modes of immune modulation predicted to be most effective. Collectively, this work establishes a new integrated framework for investigating and modulating tumor-immune networks and provides insights into how such interactions may shape early stages of tumor formation.

Indexed as

Models, ImmunologicalAlgorithmsCell- and Tissue-Based TherapyComputational BiologyComputer SimulationCytokinesHumansMacrophagesNeoplasmsCytokines

Identifiers

PMID25905470
PMCPMC4408028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.